SCHEMBL30726239

SCHEMBL30726239

CS(=O)(=O)N1CCC(Nc2ncc3ccc(F)c(Br)c3n2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 18/20 0.56
▸ CCNE1 P24864 16/20 0.56
▸ CCND1 P24385 13/20 0.56
▸ CDK6 Q00534 12/20 0.56
▸ CDK4 P11802 9/20 0.56
▸ CDK9 P50750 7/20 0.56
▸ CCNT1 O60563 6/20 0.56
▸ CDK1 P06493 3/20 0.56
▸ CDK5 Q00535 2/20 0.56
▸ CCNB2 O95067 1/20 0.56
▸ CCNE2 O96020 1/20 0.56
▸ CCNB1 P14635 1/20 0.56
▸ CDK5R1 Q15078 1/20 0.56
▸ CCNB3 Q8WWL7 1/20 0.56
▸ IKBKB O14920 1/20 0.51
▸ CASK O14936 1/20 0.51
▸ ROCK2 O75116 1/20 0.51
▸ CDKL5 O76039 1/20 0.51
▸ STK10 O94804 1/20 0.51
▸ CDK14 O94921 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27033385 1.00 CDK2 (0.56) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL27063563 0.83 EGFR (0.40) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL30726201 0.82 CDK2 (0.55) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL27033299 0.82 CDK2 (0.55) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL29754906 0.78 CDK2 (0.60) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL30768098 0.77 CCNE1 (0.56) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL27034859 0.77 CCNE1 (0.56) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL27358142 0.77 CDK2 (0.53) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL5002277 0.76 CCNE1 (0.56) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL29594774 0.76 CDK2 (0.56) CDK2CCNE1CCND1CDK6CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558493-A1 QUINAZOLINE COMPOUNDS AND METHODS OF USE Iambic Therapeutics, Inc. (US) 2025-05-28 — — EP disclosed
CN-119894880-A Quinazoline compounds and methods of use 依安彼克医疗有限公司 2025-04-25 — — CN disclosed
WO-2024020380-A1 QUINAZOLINE COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS, INC. (US) 2024-01-25 — — WO disclosed
Send feedback